Clinical Trials Browser

Completed × INDUSTRY × epratuzumab × Clear all

NCT00421395 2021-08-16

Safety Study of NHL With 90Y-hLL2 IgG

Phase 1/2 Completed

Lymphoma, Non-Hodgkin

NCT00044902 2007-12-28

Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

Phase 2 Completed

Lymphoma, Non-Hodgkin